Table 3.

Daily National Early Warning Score ≥ 5 ratio

	Use of regdanvimab	No use of regdanvimab	p value
Day 1 (n = 378)  Use of regdanvimab: 189  No use of regdanvimab: 189	9 (4.8%)	8 (4.2%)	0.804
Day 2 (n = 378)  Use of regdanvimab: 189  No use of regdanvimab: 189	16 (8.5%)	18 (9.5%)	0.719
Day 3 (n = 376)  Use of regdanvimab: 189  No use of regdanvimab: 187	6 (3.2%)	18 (9.6%)	0.011
Day 4 (n = 370)  Use of regdanvimab: 189  No use of regdanvimab: 181	9 (4.8%)	16 (8.8%)	0.118
Day 5 (n = 363)  Use of regdanvimab: 188  No use of regdanvimab: 175	7 (3.7%)	15 (8.6%)	0.053
Day 6 (n = 360)  Use of regdanvimab: 187  No use of regdanvimab: 173	6 (3.2%)	13 (7.5%)	0.068
Day 7 (n = 358)  Use of regdanvimab: 186  No use of regdanvimab: 172	7 (3.8%)	14 (8.1%)	0.078
Day 8 (n = 350)  Use of regdanvimab: 182  No use of regdanvimab: 168	7 (3.8%)	17 (10.1%)	0.020
Day 9 (n = 340)  Use of regdanvimab: 177  No use of regdanvimab: 163	6 (3.4%)	11 (6.7%)	0.156
Day 10 (n = 315)  Use of regdanvimab: 169  No use of regdanvimab: 146	8 (4.7%)	12 (8.2%)	0.206
Day 11 (n = 250)  Use of regdanvimab: 135  No use of regdanvimab: 115	8 (5.9%)	8 (7.0%)	0.740
Day 12 (n = 83)  Use of regdanvimab: 45  No use of regdanvimab: 38	5 (11.1%)	8 (21.1%)	0.214
Day 13 (n = 58)  Use of regdanvimab: 30  No use of regdanvimab: 28	6 (20.0%)	9 (32.1%)	0.291
Day 14 (n = 46)  Use of regdanvimab: 25  No use of regdanvimab: 21	6 (24.0%)	9 (45.0%)	0.138